title: Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
abstract: The Fc region has two highly conserved methionine residues, Met 33 (C(H)3 domain) and Met 209 (C(H)3 domain), which are important for the Fc's structure and biological function. To understand the effect of methionine oxidation on the structure and stability of the human IgG1 Fc expressed in Escherichia coli, we have characterized the fully oxidized Fc using biophysical (DSC, CD, and NMR) and bioanalytical (SEC and RP-HPLC-MS) methods. Methionine oxidation resulted in a detectable secondary and tertiary structural alteration measured by circular dichroism. This is further supported by the NMR data. The HSQC spectral changes indicate the structures of both C(H)2 and C(H)3 domains are affected by methionine oxidation. The melting temperature (Tm) of the C(H)2 domain of the human IgG1 Fc was significantly reduced upon methionine oxidation, while the melting temperature of the C(H)3 domain was only affected slightly. The change in the C(H)2 domain T m depended on the extent of oxidation of both Met 33 and Met 209. This was confirmed by DSC analysis of methionine-oxidized samples of two site specific methionine mutants. When incubated at 45 degrees C, the oxidized Fc exhibited an increased aggregation rate. In addition, the oxidized Fc displayed an increased deamidation (at pH 7.4) rate at the Asn 67 and Asn 96 sites, both located on the C(H)2 domain, while the deamidation rates of the other residues were not affected. The methionine oxidation resulted in changes in the structure and stability of the Fc, which are primarily localized to the C(H)2 domain. These changes can impact the Fc's physical and covalent stability and potentially its biological functions; therefore, it is critical to monitor and control methionine oxidation during manufacturing and storage of protein therapeutics.
authors.affiliation: Department of Pharmaceutics, Amgen, Inc., Thousand Oaks, California 91320, USA. liud@amgen.com
authors.forename: Dingjiang
authors.initials: D
authors.lastname: Liu
authors.forename: Da
authors.initials: D
authors.lastname: Ren
authors.forename: Holly
authors.initials: H
authors.lastname: Huang
authors.forename: Jane
authors.initials: J
authors.lastname: Dankberg
authors.forename: Robert
authors.initials: R
authors.lastname: Rosenfeld
authors.forename: Melanie J
authors.initials: MJ
authors.lastname: Cocco
authors.forename: Luke
authors.initials: L
authors.lastname: Li
authors.forename: David N
authors.initials: DN
authors.lastname: Brems
authors.forename: Richard L
authors.initials: RL
authors.lastname: Remmele
mesh_terms: D000595:Amino Acid Sequence; D002851:Chromatography, High Pressure Liquid; D002942:Circular Dichroism; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000737:chemistry* / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D007074:Immunoglobulin G / Q000737:chemistry* / Q000235:genetics / Q000276:immunology*; D007700:Kinetics; D008715:Methionine / Q000378:metabolism; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D019906:Nuclear Magnetic Resonance, Biomolecular; D010084:Oxidation-Reduction; D011489:Protein Denaturation; D017434:Protein Structure, Tertiary; D013696:Temperature
chemical_list: D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D008715:Methionine